A Dark Vector Cognition product

Item 1A. Risk Factors

3K characters. Original on sec.gov · Markdown

Item 1A. Risk Factors

There have been no material changes in our risk factors from those disclosed in Part I, Item 1A in our annual report on Form 10-K for the year ended December 31, 2022.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

PeriodTotal number of shares (or units) purchased (1)Average price paid per share (or unit)Total number of shares (or units) purchased as part of publicly announced plans or programs (2)Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs (3)
January 1, 2023 - January 31, 2023
Open Market Purchases375,573$133.03375,100
February 1, 2023 - February 28, 2023
Open Market Purchases538,124$134.02339,286
March 1, 2023 - March 31, 2023
Open Market Purchases518,483$114.65508,120
Total1,432,180$126.751,222,506$649million

(1)In accordance with the terms of its equity compensation plans, Allstate acquired the following shares in connection with the vesting of restricted stock units and performance stock awards and the exercise of stock options held by employees and/or directors. The shares were acquired in satisfaction of withholding taxes due upon exercise or vesting and in payment of the exercise price of the options.

January: 473

February: 198,838

March: 10,363

(2)From time to time, repurchases under our programs are executed under the terms of a pre-set trading plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934.

(3)In August 2021, we announced the approval of a common share repurchase program for $5 billion. The Inflation Reduction Act, enacted in August 2022 imposes a 1% excise tax on stock repurchases occurring after December 31, 2022. The excise tax on stock repurchases is classified as an additional cost of the stock acquired included in treasury stock in shareholders’ equity*.*

First Quarter 2023 Form 10-Q 77

Previous: Item 4. Controls and Procedures · Next: Item 6. Exhibits